Navigation Links
Par Pharmaceutical Begins Shipment of Generic Miacalcin(R)
Date:6/9/2009

WOODCLIFF LAKE, N.J., June 9 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it began shipping calcitonin-salmon nasal spray to the trade. Calcitonin-salmon nasal spray is a generic version of Novartis' Miacalcin(R). Annual U.S. sales of Miacalcin were approximately $112 million in 2008, according to IMS Health data.

Important information about calcitonin-salmon nasal spray

Calcitonin-salmon nasal spray is indicated for the treatment of postmenopausal osteoporosis in females greater than 5 years post menopause with low bone mass relative to healthy premenopausal females.

Calcitonin-salmon nasal spray should be reserved for patients who refuse or cannot tolerate estrogens or in whom estrogens are contraindicated.

Because Calcitonin is a polypeptide, the possibility of a systemic allergic reaction exists.

Please read full prescribing information available at www.parpharm.com/products.

About Par

Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit www.parpharm.com.

Safe Harbor Statement

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward-looking and, as such, are subject to known and unknown risks, uncertainti
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
2. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
3. Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
4. Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
6. Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications
7. Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering
8. Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
9. Isis Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference
10. Mylans Chief Operating Officer Heather Bresch to Testify Before Congress Concerning Patent Settlements Between Brand and Generic Pharmaceutical Companies and Tactics That Delay Market Entry of High Quality, Affordable Generic Drugs
11. ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., Dec. 4 Thousands of KPMG LLP emp...nwide today, to participate in a community service...firm,s support for literacy with charitable giving...irm,s long history of volunteerism. Instead of hol... of caring to brighten the holidays for some child...
(Date:12/4/2009)... Dec. 4 The American As...SA) applauds the Senate for ensuring that the Com...isions remain in the final health reform legislati...ing support to elders, people with disabilities an...ass a health care reform bill that will make it af...
(Date:12/4/2009)...ADISON HEIGHTS, Mich., Dec. 4 The ... of BetterInvesting Magazine today announced Al..."Stock to Study" and C.R. Bard, Inc. (NYSE: BC...nvestors, informational and educational use. ,,...pportunities involving its flagship drug Botox and...
(Date:12/4/2009)...N, Dec. 4 In response t...ncy,s (DEA) classification of boldione, desoxymeth...one as "anabolic steroids", under the Controlled S...and CEO of the Natural Products Association (NPA),...nting retailers and manufacturers of dietary suppl...
(Date:12/4/2009)... scientists at Johns Hopkins publishing in the Dec...in made by a gene called "Twist" may be the prover... cells that drive aggressive, metastatic breast ca...on recent work suggesting that it is a relatively ...drives breast cancer, scientists have surmised tha...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
... Providence, RI Using a new tool designed to mea...pical gels designed to prevent the sexual transmis...nd Brown University found that women who have used...safe and effective microbicide has not been identi...
...eaturing Emmy award-winning composer, Yale profess..., March 3 Gary Malkin, Emmy,award-winning compose...,Association of Professional Chaplains Annual Conf...ing is,the life work of our member chaplains," say...
...cyou offers a free online healthcare video and inf...munity, CHARLESTON, S.C., March 3 Today Benefitf...ta site icyou ( http://www.icyou.com ),which merge...althcare videos, as well as communicate with other...
... EVANSTON, Ill. --- Although researchers have lon...es than boys, until now no one has clearly provide...fferences. , For the first time -- and in unambi... harder in girls than in boys during language task...
...tudy says breathing-related problems more likely i...thDay News) -- Obese children are much more likely...ated problems during surgery, says a University of...ctive, non-cardiac surgery, found that obese child...
...OLMDEL, N.J., March 3 Sparta Systems, Inc. (Spart...r in enterprise quality and,compliance management ...leading developer and manufacturer of sterile inje... complexity of the pharmaceutical field, companies...
Other Medicine News:Health News:Researchers develop new tool to predict who will use microbicides 2Health News:Researchers develop new tool to predict who will use microbicides 3Health News:Spiritual Health Experts Speak at Chaplains Conference in Pittsburgh March 8-12 2Health News:Benefitfocus(R) Healthcare Video Portal Merges Community with Credibility 2Health News:Gender differences in language appear biological 2Health News:Gender differences in language appear biological 3Health News:Obese Children Face More Complications During Surgery 2Health News:Bioniche Pharma Chooses TrackWise for its Deviation Control Solution 2
(Date:12/3/2009)... , NEW YORK, Dec. 3 Guidepo... today announced the launch of their Sleep Apnea T...onitors and projects trends and market share in th...pnea Tracker captures actual patient usage for 87 ...ed States from 15 different equipment providers go...
(Date:12/3/2009)... , DOYLESTOWN, Pa., Dec. 3 /PRNewswire-F...uigley Corporation, (Nasdaq: QGLY ) www.quigleyc...ted its evaluation of its opportunities to develop...has concluded that it is in its best interests to ...ce, which may include but are not limited to its C...
(Date:12/3/2009)... , FORT WORTH, Texas, Dec. 3 /PRNewsw... Inc. (OTC Bulletin Board: WNDM), a rapidly growin...d today an agreement with the Health Industry Repr...clusive independent sales and marketing representa...; product within the U.S. ,, HIRA will marke...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cadus Reports Third Quarter 2009 Results 14855 1Cadus Reports Third Quarter 2009 Results 14855 2Cadus Reports Third Quarter 2009 Results 14855 3Cadus Reports Third Quarter 2009 Results 14855 4Cadus Reports Third Quarter 2009 Results 14855 5New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 1New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 2New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 3New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 4Indiana University receives NIH grant to improve health care in East Africa 61442 1Indiana University receives NIH grant to improve health care in East Africa 61442 2Indiana University receives NIH grant to improve health care in East Africa 61442 3
...k™ Cell and Tissue Adhesive is a formulation ...ulis (marine mussel). These proteins are the key c...chor itself to solid substrates in its marine envi...sed to attach cells or tissue sections to many typ...
Marquette T-Wave Alternans (TWA) Analysis
Affinity™ SR Pacemakers
...EM EZ is a small bench top chemistry analyzer that...formed on reagent strips with results available wi...s per hour. The instrument accepts whole blood sam...e of a magnetic card. At the conclusion of testing...
Medicine Products: